---
title: "Saudi Chemical Co. Unit Gets Regulatory Nod for Local Stroke, Heart Attack Drug Production"
date: "2025-02-10 12:38:13"
summary: "The Saudi Food and Drug Authority approved the local production of AJA Pharmaceutical Industries' heart and stroke medication. The Saudi Chemical Co. (SASE:2230) subsidiary previously signed a contract with the Local Content and Government Procurement Authority for the knowledge transfer and local manufacturing of Ticagrelor, according to a Sunday release...."
categories:
  - "MT Newswires"
lang:
  - "en"
translations:
  - "en"
tags:
  - "MT Newswires"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

The Saudi Food and Drug Authority approved the local production of AJA Pharmaceutical Industries' heart and stroke medication.

The Saudi Chemical Co. (SASE:2230) subsidiary previously signed a contract with the Local Content and Government Procurement Authority for the knowledge transfer and local manufacturing of Ticagrelor, according to a Sunday release.

The pharmaceutical company anticipates an increase in revenue of 35 million Saudi riyals over five years following the product's launch.

[MT Newswires](https://www.tradingview.com/news/mtnewswires.com:20250209:G2465410:0/)
